Compare DexCom, Inc. (DXCM) vs iShares JPMorgan USD Emerging Markets Bond ETF (EMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs iShares JPMorgan USD Emerging Markets Bond ETF — how do they compare? DexCom, Inc. trades at $77.68 (market cap $28.06B), while iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.52. Which is the better fit depends on your goals.
| DXCM | EMB | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | Fixed Income |
52-Week High | $89.53 | $97.74 |
52-Week Low | $54.84 | $91.59 |
Enterprise Value | $27.03B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →
